Sponsor pipeline

Apellis Pharmaceuticals clinical trial pipeline

4 active trials 2 recruiting 1 Phase 3

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

Active trials by phase

Phase 2		2
Phase 3		1

Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

NCT ID	Title	Condition	Status	Updated
Phase 3
NCT05809531	An Open-Label, Nonrandomized, Multicenter Extension Study to Evaluate the Long-term…	C3G	Active, Not Recruiting	2026-04-02
Phase 2
NCT04901936	A Study of Pegcetacoplan in Pediatric Patients With Paroxysmal Nocturnal Hemoglobinuria…	Paroxysmal Nocturnal Hemoglobinuria (PNH)	Recruiting	2026-06-26
NCT07215390	A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the…	Geographic Atrophy Secondary to Age-related Macular Degeneration	Recruiting	2026-06-24
Not specified
NCT06161584	A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate…	Geographic Atrophy	Active, Not Recruiting	2026-06-01

Get alerts when Apellis Pharmaceuticals's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.